Inspire Medical Systems Sets Strategic Update for J.P. Morgan Healthcare Conference

Minneapolis, Monday, 29 December 2025.
Inspire Medical Systems (NYSE: INSP) is scheduled to present at the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026, offering a pivotal update for the investment community. This presentation comes at a critical juncture for the Minneapolis-based medical technology firm. While Inspire recently reported robust Q3 2025 financials—including a 10% revenue increase to $224.5 million and raised full-year guidance—the company is simultaneously navigating shareholder litigation regarding its Inspire V launch. With the stock trading around $95.47 as of late December 2025, investors will be keenly focused on management’s strategy to sustain growth in the obstructive sleep apnea market while addressing these operational and legal headwinds.